Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
15.72
+0.58 (3.83%)
Oct 8, 2025, 11:52 AM EDT - Market open
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $1.66 billion as of October 8, 2025. Its market cap has decreased by -37.55% in one year.
Market Cap
1.66B
Enterprise Value
1.01B
1-Year Change
-37.55%
Ranking
Category
Stock Price
$15.72
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $1.66B, an increase of 117.59%. That is a compound annual growth rate of 18.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 1.59B | -36.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.11B |
| Johnson & Johnson | 452.72B |
| AbbVie | 413.06B |
| UnitedHealth Group | 328.28B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.44B |